Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_assertion type Assertion NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_head.
- NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_assertion description "[As an example, we predicted that RAD50 with TRF2 have prostate cancer specific interaction that turned out to be having validation from the literature.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_provenance.
- NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_assertion evidence source_evidence_literature NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_provenance.
- NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_assertion SIO_000772 21777411 NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_provenance.
- NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_assertion wasDerivedFrom befree-20140225 NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_provenance.
- NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_assertion wasGeneratedBy ECO_0000203 NP916170.RAFcEiQWSZNHTWZUoyKtbCbmySVwBJZ2sp3sMX3ionTx0130_provenance.